Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Aquestive Therapeutics price target lowered to $7 from $10 at Lake Street
Aquestive Therapeutics price target lowered to $7 from $8 at RBC Capital »
Aquestive Therapeutics price target lowered to $13 from $18 at BMO Capital 07:00 AQST BMO Capital analyst Gary Nachman lowered the firm's price target on Aquestive Therapeutics to $13 from $18 but keeps an Outperform rating on the shares. The analyst notes that the CRL for the company's key product Libervant announced by the FDA on Friday is "disappointing, but should be very fixable" in the near term. Nachman adds that Aquestive intends to resubmit the study by the end of the year and expects a PDUFA date for the drug in the first half of 2021.
Read more at:
https://thefly.com/n.php?id=3166457
Aquestive Therapeutics price target lowered to $17 from $23 at JMP
Aquestive Therapeutics price target lowered to $17 from $23 at JMP Securities 06:07 AQST JMP Securities analyst Jason Butler lowered the firm's price target on Aquestive Therapeutics to $17 from $23 but keeps an Outperform rating on the shares. The analyst notes that the company's announcement of an FDA CRL for Libervant announced on Friday is disappointing, but he believes that the path to approval remains "timely and low risk". Butler adds that his probability of approval for the drug remains at 85%, though his model pushes back assumptions for its launch and first sales by one year to 2021.
Read more at:
https://thefly.com/n.php?id=3166393Securities »
https://thefly.com/news.php?symbol=AQST
Way over raction-- I am buying more on Monday. Looks like a good opportunity.
Patience
It looks like a minor fixable issue. People can sell their shares to me for a sub $4 price and I will scoop them up.
What was discovered were minor issues that will be easily addressed. Read the CRL and you will see that the expected new PDUFA will probably be 1Q 2021. I do hope they do not dilute before then.
https://www.sec.gov/Archives/edgar/data/1398733/000114036120021614/brhc10015485_ex99-3.htm
Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant™ (diazepam)
pipeline is great. a lot happening next few months. Analysts like this a lot
* * $AQST Video Chart 08-18-2020 * *
Link to Video - click here to watch the technical chart video
Pretty good bounce today though
12 down days in a row : ( Ironically, last year in July-August, $AQST was 17 days down in a row before their earning pushed it higher.
$3.70-3.80 is possible based on the chart. If you believe in Gap Fills, the 4/13-4/14 fill would give us $3.37 price.
There is nothing fundamentally wrong with the stock. We are just in a dead period with no news so people are selling.
GLTA
Filled at $4.25. Next buy will be around $4. I need $AQST to form a base before I put a limit order in. It could break into the $3 too.
I might get my $4.52 price today!.....next buy in is $4.30 and the truck will be backed up!
Upcoming PDUFA 9/27/20
PDUFA 3/02/21
Never posted anything like this but maybe a buyout target with all their potential!
I hope you guys bought on the dip!
This is going to be big!!!!
AQST$$$
This technology is SUCH a big deal for these patient's. The ability to swallow pills, even 00 gel caps (500mg) is a major concern for those that cannot swallow or struggle doing so.
The cherry (please excuse the term) is suboxone, fentanyl (eventually?), and other pain meds that need to be single dosed.
It looks like the chart want to form a base but the volume is predictably drying up.
$4.50 and below is still my buy in.
This is a great buy $$$$ FDA approval Parkinson’s drug should be available in the US in September!!
Amen brother, great buying opportunity, gonna be another run up to PDUFA 9/27/2020
We will see but I am expecting AQST to fall a bit in June-July and it isn't because it deserves to.
$4.50 is first buy in.
In 5 years, it won't matter....this is going to be a monster!
PDUFA 9/27/2020
PDUFA 3/02/2021
I hope 1 or 2 surprises.... Going below $5?
Next catalysts?
Does Diazepam have a catalyst / PDUFA date set this year?
Is Aquestive looking at all ready approved microgram drugs like Fentanyl, etc.?
I currently own a nice chunk of this stock I will be accumulating in June when the price goes below $4.50. It is my #1 small cap right now and I am holding for 5 + years.
GLTA
Thanks brother.
Just thought that the stock would do better.
Thanks brother.
I am not quite sure i understood what you meant.
Is this it?
Definition of eat humble pie. informal. : to admit that one was wrong or accept that one has been defeated They had to eat humble pie when the rumors they were spreading were proved false.
Please clarify
I ate HUMBLE PIE all day Friday!
Mazzel Tov DorseyE.
Very well done!
Same here, let’s enjoy this and hopefully some good news with RDHL
The non-dilutive capital is really what makes the future stock price stand out! All my best and have you member marked so hope to stay in touch. ENJOY!
Same to you and all... really liked the part...
We continue to expect that we will receive between $50 to $100 million of non-dilutive capital from the monetization, in one or a series of transactions. The timing of the monetization will depend on market conditions, and will be executed at a time that is optimal for Aquestive. Based on our current planning and expectations, we believe that we are positioned well with current cash resources and proceeds from a potential monetization of this royalty stream to extend our capital runway well into 2021 and possibly beyond.”
Hey, buddy congrats on the FDA approval! She really is a sweetheart company worth holding. News below.
Aquestive Therapeutics Inc. (AQST) Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Approval
https://www.streetinsider.com/Corporate+News/Aquestive+Therapeutics+Inc.+%28AQST%29+Advances+Royalty+Monetization+Plan+as+Sunovion+Pharmaceuticals%E2%80%99+Apomorphine+Sublingual+Film+Therapy+Receives+FDA+Approval/16919171.html
According to our latest data, AQST has moved about 9.11% on a year-to-date basis. At the same time, Medical stocks have lost an average of 1.99%. This means that Aquestive Therapeutics is performing better than its sector in terms of year-to-date returns
https://finance.yahoo.com/news/aquestive-therapeutics-aqst-outperforming-other-153003275.html
Better one bird in your cache
than 2 birds on the tree.
In your shoes i would sell
some 50% before PFUDA.
GL in whatever you decide.
I struck gold myself in a
stock i am into, NNDM
https://investorshub.advfn.com/Nano-Dimension-Ltd-ADR-NNDM-30614/
I can’t sleep tonight thinking about the possibilities!
Well said my friend and I will take your advice!
It is trading over 7.00 pre-Mkt :))
Well done DorseyE! Great!!!
In my VERY humble opinion you should
consider selling some prior to the
PDUFA.
If it gains FDA approval, it might prove
the saying: Buy the rumor - sell the news.
(You have been in a similar situation)
Yeah I think I’m going to sell some this week with the PDUFA date of 7/21/202, Thursday I believe?
I 1st started buying @ 3.72
WOW. just took a peak AH 6.65!
Thanks I’m new here myself just stumbled on this stock this year... thanks for your input.
Hello all,
I have been a holder in $AQST for over a year and have been actively promoting on Twitter lately. Their patented film technology is going to make a significant contribution to the delivery of meds, especially for already approved meds (generics) meds that deliver in mcgs.
GTLA
Good call so far buddy!!!! :)
Next up...... THE BIG WEEK!!!!
PDUFA 5/21/2020!!!
Aquestive Therapeutics (AQST) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Aquestive Therapeutics (AQST) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
Mazzel Tov To you too!
I just bought another 800 shares, hoping for the best, C’mon 5/21/2020
Added more to my great nieces/nephews college fund today @4.68.... yeah my baby niece had triplets on us, so it’s going to be costly!
Added more to my great nieces/nephews college fund today @4.68.... yeah my baby niece had triplets on us, so it’s going to be costly!
Followers
|
20
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
198
|
Created
|
11/07/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |